Search Results
Safety of JAKs: Venou Thromboemboic Risk by Dr. Kevin Winthrop
Insights at ACR 2020: Efficacy and Safety of JAK Inhibitors
Insights at EULAR 2020: Safety of JAK Inhibitors
Leveraging JAK Inhibitors in Ulcerative Colitis: Strategies for the IBD Management Team
Discussing Rheumatology: Safety of filgotinib, and tofacitinib in pJIA
Rheumatoid Arthritis: Integrating Patient-Centered Management
From Pathways to PROs: Translating Latest Evidence for JAK Inhibitors to Clinical Practice
Clinical Application of Recommendations on Use of JAKi in Inflammatory Arthritis (Webinar)
General Internal Medicine Grand Rounds Nov 12, 2019
The COVID-19 Vaccine Landscape: What a Rheumatologist Needs to Know - Interview with James Galloway
JAK inhibitors in rheumatic diseases
Rheumatology Author Professor Paul Bird: Tofacitinib Effectiveness
